Protocol: An Observational Study of the Development of Diabetic Macular Edema Following Scatter Laser Photocoagulation Status: Closed Start Date: 09/29/2005 End Date: 01/31/2008 Clinical Trial ID: NCT00687154 Public Dataset: Download An Observational Study of the Development of Diabetic Macular Edema Following Scatter Laser Photocoagulation Protocol Status: Completed "Click here to view protocol" A. Study Design Prospective, multi-center nonrandomized treatment study B. Objectives To determine the incidence and extent of macular edema following scatter laser photocoagulation surgery using optical coherence tomography (OCT) in eyes without macular edema prior to scatter laser photocoagulation. To explore whether the incidence and extent of macular edema varies according to the number of sittings included in the treatement regimen. C. Major Eligibility Criteria Age >=18 years. Study eye with (1) OCT central subfield thickness <= 299 microns and (2) early proliferative or severe nonproliferative diabetic retinopathy for which investigator intends to perform full scatter photocoagulation in either 1 sitting or 4 sittings. D. Treatment Study eyes will receive scatter photocoagulation given by one of the following two regimens to be selected by the investigator at his/her discretion: 1 sitting with a minimum of 1200 to a maximum of 1600 burns, with one burn width separation of burns and scatter extending from the peripheral arcades to beyond the equator. 4 sittings, each separated by four weeks (+4 days), with approximately 300 burns in each of the first two sittings and investigator judgment for number of burns for the third and fourth sittings as long as the total for the four sittings is between 1200 and 1600 burns E. Duration of follow-up: 34 weeks F. Main Outcomes Primary Retinal thickening (measured with OCT). Secondary Visual acuity (measured with E-ETDRS). G. Sample Size: 150 eyes H. Schedule of Study Visits and Examination Procedures Study Visits 0 2-4 days 4 wks 8 wks* 12 wks* 17 wks 34 wks E-ETDRS visual acuity Xa X X Xa Xa Fundus photos b 7F 3F OCT X X X X X Dilated Fundus Exam X PRP Treatment X X* X* X* HbA1c c X Blood pressure X *For patients in the 4-sitting group only (exam data not collected at 8 or 12 weeks from the first sitting) a = includes protocol refraction. E-ETDRS refers to electronic ETDRS testing using the Electronic Visual Acuity Tester that has been validated against 4-meter chart ETDRS testing. b = post-treatment posterior pole (ETDRS field 2) and one peripheral field photos will be taken on the day of the first PRP sitting. c = does not need to be repeated if HbA1c and lab normal values are available from within the prior 3 months (at baseline, can be performed within 3 weeks after enrollment). Back